- Report
- October 2024
- 180 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- February 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- February 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Drug Pipelines
- August 2024
- 150 Pages
Global
From €2643EUR$2,789USD£2,208GBP
- Report
- February 2024
- 86 Pages
Global
From €3500EUR$3,956USD£3,026GBP
Divalproex Sodium is a drug used to treat various conditions related to the Central Nervous System (CNS). It is an anticonvulsant and mood stabilizer used to treat epilepsy, bipolar disorder, and migraine headaches. It is also used to treat certain psychiatric disorders, such as schizophrenia and schizoaffective disorder. Divalproex Sodium is available in both immediate-release and extended-release formulations. The extended-release formulation is used to treat manic episodes associated with bipolar disorder.
Divalproex Sodium is a widely used drug in the CNS market. It is generally well-tolerated and has a low risk of side effects. It is also relatively inexpensive compared to other CNS drugs.
Some companies in the Divalproex Sodium market include AbbVie, Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more